For the week (Monday 23 March to Friday April 3) the COVID-19 index lost 4% with 9 gainers against 14 fallers. The biggest riser waswith an 18% gain for the week with the worst performer being , which gave up all-time highs of 73.5p the previous week to finish the week at 48.5p. The worst performing sector in the index was Healthcare with all bar finishing the week lower.
Special mention must be given to, which finished the week 18% higher, largely due to a late rally on Friday after announcing the Company had installed one of its Point of Care Ultrasound Simulators (“PoCUS”), at the new Nightingale Hospital in London, to help train front line workers diagnose COVID-19.
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
AstraZeneca said it will be able to supply two billion doses of a potential virus vaccine following two new deals. Last month, AstraZeneca said it could manufacture one billion doses, that it is developing with scientists at Oxford University but yesterday after signing two deals, including one backed by Bill Gates, means it can double production.
Cluff said it is ‘fully committed’ to drilling a Shell-partnered North Sea prospect, but that drilling at the Selene prospect is now expected to start in 2022. Meanwhile, the Company remains fully funded for all its other planned drilling operations.